ACTSI Investigator Dr. Vinod Thourani in the News

Vinod Thourani, MD, ACTSI investigator, Associate Professor of Surgery, Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine; Co-Director, Structural Heart and Valve Center of the Emory Heart and Vascular Center; Associate Director, Cardiothoracic Surgery Residency Program, Emory University School of Medicine; Associate Director, Cardiothoracic Surgery Clinical Research Unit, Emory University School of Medicine

Reuters | Business Week | Fox Business | Edwards heart valve system good as surgery at 3 years-trial
March 11, 2013

Emory Medicine Magazine | A no-crack solution to aortic stenosis
Spring 2012

HealthCanal.com | New valve revolutionizes the treatment of aortic stenosis
November 3, 2011

Health Sciences Magazine | An alternative to cracking the chest
Spring 2011

The FDA approved the SAPIEN transfemoral transcatheter heart valve for severe aortic stenosis. Robert Guyton and Vinod Thourani (cardiothoracic surgery) were the local surgical co-principal investigators in a multicenter trial that led to the approval of the Edwards Lifesciences valve. Thourani's start-up company, Apica Cardiovascular, recently received corporate investment to advance development of a device that will simplify the technique for opening and closing the beating heart during surgery and help minimize bleeding and the heart's exposure to air.

Upcoming Events

View All Events

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?